As we reported last month, Purdue’s new version of OxyContin has done little to address the epidemic of addiction its painkiller has caused. Not only are addicts figuring out ways to abuse OP, they’re also increasingly turning to other prescription drugs with oxycodone, such as Percocet 30s and Roxycodone – as well as the painkiller Opana, according to this article in the New York Times. They’re also turning to heroin, which is cheaper and provides the same high. Purdue’s comment on these developments? The company is “cautiously optimistic” that the reformulation will eventually prove less susceptible to abuse but says it’s “still too early to make any conclusions about the product’s impact on abuse and misuse in real-world settings,” the article says.
Let’s get real. Purdue didn’t take OxyContin off the market because it’s making money hand over fist – it just found a way to make even MORE money hand over fist.